BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27835582)

  • 21. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
    Xu YH; Zhang GB; Wang JM; Hu HC
    Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.
    Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J
    Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis.
    Ye Z; Zheng Z; Li X; Zhu Y; Zhong Z; Peng L; Wu Y
    Cell Physiol Biochem; 2016; 39(4):1568-80. PubMed ID: 27626927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis.
    Sun H; Gao F; Liu Y; Shao J
    BMC Urol; 2024 Mar; 24(1):57. PubMed ID: 38468228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.
    Jiang LY; Bi R; Ding FB; Wang MS; Mei J; He Y
    J BUON; 2016; 21(2):341-8. PubMed ID: 27273943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
    Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
    J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.
    Zhang X; Tian T; Zhang X; Liu C; Fang X
    Oncotarget; 2017 Jun; 8(23):37673-37680. PubMed ID: 28445149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    Mitchell KG; Parra ER; Nelson DB; Zhang J; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):911-919.e6. PubMed ID: 31235357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-H6 expression in non-small cell lung cancers.
    Zhang X; Zhang G; Qin Y; Bai R; Huang J
    Int J Clin Exp Pathol; 2014; 7(10):6936-42. PubMed ID: 25400778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.
    Boland JM; Kwon ED; Harrington SM; Wampfler JA; Tang H; Yang P; Aubry MC
    Clin Lung Cancer; 2013 Mar; 14(2):157-63. PubMed ID: 22868219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
    Zhu J; Li Q; He JT; Liu GY
    Int J Clin Exp Pathol; 2015; 8(12):15801-7. PubMed ID: 26884850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
    Wang Y; Lu Y; Li J; Wu Y; Che G
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.